PMID- 19289123 OWN - NLM STAT- MEDLINE DCOM- 20090414 LR - 20181201 IS - 1873-3468 (Electronic) IS - 0014-5793 (Linking) VI - 583 IP - 7 DP - 2009 Apr 2 TI - Interleukin-1beta is a positive regulator of TIARP/STAMP2 gene and protein expression in adipocytes in vitro. PG - 1196-200 LID - 10.1016/j.febslet.2009.03.015 [doi] AB - The impact of interleukin (IL)-1beta on tumor necrosis factor alpha-induced adipose-related protein (TIARP)/six-transmembrane protein of prostate 2 (STAMP2) was determined in adipocytes. TIARP/STAMP2 mRNA synthesis was significantly stimulated by IL-1beta in a dose- and time-dependent fashion in 3T3-L1 adipocytes. Signaling studies suggested that janus kinase 2, nuclear factor kappaB, and p44/42 mitogen-activated protein kinase are involved in IL-1beta-induced TIARP/STAMP2 mRNA expression. Furthermore, IL-1beta, TNFalpha, and IL-6 showed synergistic stimulatory effects on TIARP/STAMP2 gene expression. Moreover, both TIARP/STAMP2 mRNA synthesis and protein expression were induced by IL-1beta in fully differentiated human mesenchymal stem cell-derived adipocytes (hMSC-Ad). Taken together, TIARP/STAMP2 is highly upregulated in 3T3-L1 cells and hMSC-Ad by IL-1beta and might, therefore, modulate proinflammatory and insulin resistance-inducing effects of IL-1beta. FAU - Kralisch, Susan AU - Kralisch S AD - University of Leipzig, Department of Internal Medicine III, Leipzig, Germany. FAU - Sommer, Grit AU - Sommer G FAU - Weise, Sebastian AU - Weise S FAU - Lipfert, Jana AU - Lipfert J FAU - Lossner, Ulrike AU - Lossner U FAU - Kamprad, Manja AU - Kamprad M FAU - Schrock, Kathleen AU - Schrock K FAU - Bluher, Matthias AU - Bluher M FAU - Stumvoll, Michael AU - Stumvoll M FAU - Fasshauer, Mathias AU - Fasshauer M LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20090314 PL - England TA - FEBS Lett JT - FEBS letters JID - 0155157 RN - 0 (IL6 protein, human) RN - 0 (Interleukin-1beta) RN - 0 (Interleukin-6) RN - 0 (Membrane Proteins) RN - 0 (NF-kappa B) RN - 0 (RNA, Messenger) RN - 0 (Tiarp protein, mouse) RN - 0 (Tumor Necrosis Factor-alpha) RN - EC 1.- (Oxidoreductases) RN - EC 1.16.1.- (STEAP4 protein, human) RN - EC 2.7.10.2 (JAK2 protein, human) RN - EC 2.7.10.2 (Jak2 protein, mouse) RN - EC 2.7.10.2 (Janus Kinase 2) RN - EC 2.7.11.24 (Mitogen-Activated Protein Kinase 1) SB - IM MH - 3T3-L1 Cells MH - Adipocytes/cytology/*metabolism MH - Animals MH - Cell Differentiation/drug effects/physiology MH - Dose-Response Relationship, Drug MH - Drug Synergism MH - Gene Expression Regulation/*drug effects/physiology MH - Humans MH - Insulin Resistance/physiology MH - Interleukin-1beta/agonists/*pharmacology MH - Interleukin-6/agonists/pharmacology MH - Janus Kinase 2/metabolism MH - Membrane Proteins/*biosynthesis MH - Mesenchymal Stem Cells/cytology/metabolism MH - Mice MH - Mitogen-Activated Protein Kinase 1/metabolism MH - NF-kappa B/metabolism MH - Oxidoreductases/*biosynthesis MH - RNA, Messenger/biosynthesis MH - Tumor Necrosis Factor-alpha/agonists/pharmacology EDAT- 2009/03/18 09:00 MHDA- 2009/04/15 09:00 CRDT- 2009/03/18 09:00 PHST- 2009/02/06 00:00 [received] PHST- 2009/03/01 00:00 [revised] PHST- 2009/03/05 00:00 [accepted] PHST- 2009/03/18 09:00 [entrez] PHST- 2009/03/18 09:00 [pubmed] PHST- 2009/04/15 09:00 [medline] AID - S0014-5793(09)00185-9 [pii] AID - 10.1016/j.febslet.2009.03.015 [doi] PST - ppublish SO - FEBS Lett. 2009 Apr 2;583(7):1196-200. doi: 10.1016/j.febslet.2009.03.015. Epub 2009 Mar 14.